Findings reveal distinct, context-dependent roles for TGF-β- and IL-1-dependent CAF states and identify myCAF-derived TGF-β signalling as a stromal mechanism promoting malignant cell plasticity.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) contains heterogeneous cancer-associated fibroblast (CAF) populations, including interleukin 1 (IL-1)-dependent inflammatory CAFs (iCAFs) and transforming growth factor beta (TGF-β)-dependent myofibroblastic CAFs (myCAFs), whose functions at primary and metastatic sites remain incompletely defined. Here, we genetically disrupted IL-1 or TGF-β signalling in fibroblast activation protein (FAP)-expressing CAFs arising from a shared cellular origin to determine how myCAF and iCAF states shape PDAC progression and microenvironments. Depletion of TGF-β-dependent myCAFs, but not IL-1-dependent iCAFs, did not alter primary tumour growth or local metastatic dissemination but significantly reduced liver and lung metastases. Matched primary tumours and liver metastasis analyses also revealed site-specific stromal responses to TGF-β signalling disruption. Experimental models of liver metastasis colonisation and outgrowth indicated that the reduced metastatic phenotype was linked primarily to alterations within pancreatic tumours rather than to impaired malignant cell outgrowth at metastatic sites. Single-cell RNA-sequencing of myCAF-depleted primary tumours revealed extensive transcriptional reprogramming across fibroblast, immune and malignant compartments, highlighting the complexity of assigning myCAF-to-malignant cell signalling mechanisms in vivo. To resolve this crosstalk, we co-cultured PDAC organoids with pancreatic stellate cells engineered to remain in myCAF or iCAF states. Cross-model transcriptomic analyses, together with genetic and pharmacological perturbation studies, showed that myCAF-derived TGF-β directly promotes epithelial-to-mesenchymal transition signalling in PDAC malignant cells, providing a candidate mechanism for the reduced metastasis observed upon myCAF depletion in vivo. These findings reveal distinct, context-dependent roles for TGF-β- and IL-1-dependent CAF states and identify myCAF-derived TGF-β signalling as a stromal mechanism promoting malignant cell plasticity. STATEMENT OF SIGNIFICANCE Manipulation of inflammatory fibroblast and myofibroblast states shows that distinct fibroblast programmes arising from a shared cellular origin differentially shape pancreatic cancer progression and context-dependent metastasis formation.
This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.
Camille Acevedo, Sayan Chakraborty, Samara P. Singh et al.· Cancer Research· 0 citations
Cancer-associated fibroblasts (CAFs) are key components of the tumour microenvironment (TME) in papillary thyroid carcinoma (PTC) and play a critical role in disease progression. We previously reported that interleukin-6 (IL-6) promotes PTC progression through activation of MAPK signalling. However, whether CAFs serve...
This review synthesizes evidence on fibroblast origins, canonical and recently reported states, and the signals that drive state transitions and examines CAF functions in extracellular matrix organization, tumor-cell plasticity and dissemination, metabolic support and immune regulation.
Yi Hao, Yi Wang, Qin-Yang Du et al.· Frontiers in Immunology· 0 citations
A reversible, growth factor-driven CAF program is defined and signaling mechanisms that may provide opportunities to selectively modulate tumor-supportive fibroblast states are identified.
M. Ibanez-Rios, M. Batardière, E. Dianati et al.· bioRxiv· 0 citations